APOB and cardiovascular disorder: A comparative analysis of the efficacy of the food therapy group and statin treatment group in mitigating the risk of cardiovascular disease revealed that the food therapy group exhibited a reduction in ApoB levels at 2 weeks (74.96 ± 23.59 mg/dL, p < 0.05) and 4 weeks (70.22 ± 21.56 mg/dL, p < 0.05) after the start of the intervention (Figure 9).